Event Type
Disclosure
Mandatory
Variant
8-K
Results of Operations and Financial Condition. On November 12, 2025, Annovis Bio, Inc. (the “Registrant”) issued a press release reporting earnings for the qu
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99 Press Release dated November 12, 2025 104 Cover Page Interactive Data